Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Director/PDMR Shareholding

9th Nov 2012 12:12

RNS Number : 7768Q
Allergy Therapeutics PLC
09 November 2012
 



9 November 2012

 

Allergy Therapeutics plc

("Allergy Therapeutics" or the "Company")

 

 

Director/PDMR Shareholding

 

Allergy Therapeutics plc (AIM: AGY), the fully integrated speciality pharmaceutical company specialising in allergy vaccines, was informed on 8 November 2012 that Mr Ian Postlethwaite, a director, sold 493,000 Ordinary Shares of 0.1p each ("Ordinary Shares") on 8 November 2012 at a price of 12.75p per Ordinary Share. Mr Postlethwaite intends to apply the proceeds of the sale towards the cost of exercising options in the Company in due course.

 

Following this disposal, Mr Ian Postlethwaite holds no Ordinary Shares and holds options and LTIPs representing 2,983,500 Ordinary Shares.

 

 

For further information

 

Allergy Therapeutics

+44 (0) 1903 845 820

Manuel Llobet, Chief Executive Officer

Ian Postlethwaite, Finance Director

www.allergytherapeutics.com

Nomura Code Securities

+44 (0) 207 776 1200

Juliet Thompson / Clare Terlouw

FTI Consulting

+44 (0) 207 831 3113

Simon Conway / Susan Stuart / Victoria Foster-Mitchell

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBDBDBGBGBGDC

Related Shares:

Allergy Thera.
FTSE 100 Latest
Value8,616.18
Change73.62